BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27521979)

  • 1. Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation.
    Squeglia LM; Baker NL; McClure EA; Tomko RL; Adisetiyo V; Gray KM
    Addict Behav; 2016 Dec; 63():172-7. PubMed ID: 27521979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial.
    Squeglia LM; Tomko RL; Baker NL; McClure EA; Book GA; Gray KM
    Drug Alcohol Depend; 2018 Apr; 185():17-22. PubMed ID: 29413434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.
    Gray KM; Sonne SC; McClure EA; Ghitza UE; Matthews AG; McRae-Clark AL; Carroll KM; Potter JS; Wiest K; Mooney LJ; Hasson A; Walsh SL; Lofwall MR; Babalonis S; Lindblad RW; Sparenborg S; Wahle A; King JS; Baker NL; Tomko RL; Haynes LF; Vandrey RG; Levin FR
    Drug Alcohol Depend; 2017 Aug; 177():249-257. PubMed ID: 28623823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of depressive symptoms in treatment of adolescent cannabis use disorder with N-Acetylcysteine.
    Tomko RL; Gilmore AK; Gray KM
    Addict Behav; 2018 Oct; 85():26-30. PubMed ID: 29803870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cigarette smoking during an N-acetylcysteine-assisted cannabis cessation trial in adolescents.
    McClure EA; Baker NL; Gray KM
    Am J Drug Alcohol Abuse; 2014 Jul; 40(4):285-91. PubMed ID: 24720376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents.
    Gray KM; Carpenter MJ; Baker NL; DeSantis SM; Kryway E; Hartwell KJ; McRae-Clark AL; Brady KT
    Am J Psychiatry; 2012 Aug; 169(8):805-12. PubMed ID: 22706327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder.
    Tomko RL; Baker NL; Hood CO; Gilmore AK; McClure EA; Squeglia LM; McRae-Clark AL; Sonne SC; Gray KM
    Psychopharmacology (Berl); 2020 Feb; 237(2):479-490. PubMed ID: 31712969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network.
    McClure EA; Sonne SC; Winhusen T; Carroll KM; Ghitza UE; McRae-Clark AL; Matthews AG; Sharma G; Van Veldhuisen P; Vandrey RG; Levin FR; Weiss RD; Lindblad R; Allen C; Mooney LJ; Haynes L; Brigham GS; Sparenborg S; Hasson AL; Gray KM
    Contemp Clin Trials; 2014 Nov; 39(2):211-23. PubMed ID: 25179587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marijuana craving trajectories in an adolescent marijuana cessation pharmacotherapy trial.
    Roten AT; Baker NL; Gray KM
    Addict Behav; 2013 Mar; 38(3):1788-91. PubMed ID: 23261493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Pretreatment Impulsivity and High Medication Adherence Increase the Odds of Abstinence in a Trial of N-Acetylcysteine in Adolescents with Cannabis Use Disorder.
    Bentzley JP; Tomko RL; Gray KM
    J Subst Abuse Treat; 2016 Apr; 63():72-7. PubMed ID: 26827257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive performance in a placebo-controlled pharmacotherapy trial for youth with marijuana dependence.
    Roten A; Baker NL; Gray KM
    Addict Behav; 2015 Jun; 45():119-23. PubMed ID: 25661990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N acetylcysteine in the treatment of alcohol use disorder: a randomized, double-blind, placebo-controlled trial.
    Morley KC; Peruch S; Adams C; Towers E; Tremonti C; Watt J; Jamshidi N; Haber PS
    Alcohol Alcohol; 2023 Sep; 58(5):553-560. PubMed ID: 37465907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetylcysteine prevents behavioral and biochemical changes induced by alcohol cessation in rats.
    Schneider R; Santos CF; Clarimundo V; Dalmaz C; Elisabetsky E; Gomez R
    Alcohol; 2015 May; 49(3):259-63. PubMed ID: 25771148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Acetylcysteine for Nonsuicidal Self-Injurious Behavior in Adolescents: An Open-Label Pilot Study.
    Cullen KR; Klimes-Dougan B; Westlund Schreiner M; Carstedt P; Marka N; Nelson K; Miller MJ; Reigstad K; Westervelt A; Gunlicks-Stoessel M; Eberly LE
    J Child Adolesc Psychopharmacol; 2018 Mar; 28(2):136-144. PubMed ID: 29053023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled Study.
    Sarris J; Oliver G; Camfield DA; Dean OM; Dowling N; Smith DJ; Murphy J; Menon R; Berk M; Blair-West S; Ng CH
    CNS Drugs; 2015 Sep; 29(9):801-9. PubMed ID: 26374743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease.
    Kasielski M; Nowak D
    Respir Med; 2001 Jun; 95(6):448-56. PubMed ID: 11421501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of N-acetylcysteine in the treatment of methamphetamine dependence: a double-blind controlled, crossover study.
    Mousavi SG; Sharbafchi MR; Salehi M; Peykanpour M; Karimian Sichani N; Maracy M
    Arch Iran Med; 2015 Jan; 18(1):28-33. PubMed ID: 25556383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of
    Todd JJ; Lawal TA; Witherspoon JW; Chrismer IC; Razaqyar MS; Punjabi M; Elliott JS; Tounkara F; Kuo A; Shelton MO; Allen C; Cosgrove MM; Linton M; Michael D; Jain MS; Waite M; Drinkard B; Wakim PG; Dowling JJ; Bönnemann CG; Emile-Backer M; Meilleur KG
    Neurology; 2020 Mar; 94(13):e1434-e1444. PubMed ID: 31941795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of N-acetylcysteine on cardiac injury and oxidative stress after abdominal aortic aneurysm repair: a randomized controlled trial.
    Mahmoud KM; Ammar AS
    Acta Anaesthesiol Scand; 2011 Sep; 55(8):1015-21. PubMed ID: 22092168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic N-acetylcysteine decreases serum CRP but not PCT levels and microalbuminuria following major abdominal surgery. A prospective, randomised, double-blinded, placebo-controlled clinical trial.
    Molnar Z; Szakmany T; Koszegi T
    Intensive Care Med; 2003 May; 29(5):749-55. PubMed ID: 12682719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.